. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Ann Allergy Asthma Immunol. 2018 Apr 27;121(1):69–76.e2. doi: 10.1016/j.anai.2018.04.020

Table 1.

Distribution of Challenge Severity Score

Cumulative Tolerated Dose (mg)	Severity Challenge Indicator(SCI)	Challenge Severity Score (CSS)	Number of Subjects (%)
175 – 375	Negative	1	15 (12.5%)
25 – 75	Negative	2	44 (36.7%)
< 25	Negative	3	39 (32.5%)
175 – 375	Positive	4	9 (7.5%)
25 – 75	Positive	5	12 (10%)
< 25	Positive	6	1 (0.8%)

Note: SCI is a measure of reaction severity.